Panagora Asset Management’s Myriad Genetics MYGN Stock Holding History

Panagora Asset Management’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17M	Buy	+204,846	New	+$930K	﹤0.01%	716
2022 Q3	–	Sell	-205,382	Closed	-$3.73M	–	1505
2022 Q2	$3.73M	Buy	205,382 +49,397	+32%	+$1.03M	0.02%	460
2022 Q1	$3.93M	Sell	155,985 -449	-0.3%	-$11.5K	0.02%	471
2021 Q4	$4.32M	Buy	156,434 +9,836	+7%	+$285K	0.02%	438
2021 Q3	$4.73M	Buy	146,598 +319	+0.2%	+$10.6K	0.03%	441
2021 Q2	$4.47M	Buy	+146,279	New	+$4.23M	0.02%	471
2017 Q3	–	Sell	-381	Closed	-$10K	–	2437
2017 Q2	$10K	Buy	+381	New	+$8.09K	﹤0.01%	2412
2016 Q3	–	Sell	-1,850	Closed	-$57K	–	2442
2016 Q2	$57K	Sell	1,850 -34,822	-95%	-$1.21M	﹤0.01%	2036
2016 Q1	$1.37M	Buy	36,672 +28,279	+337%	+$1.07M	0.01%	985
2015 Q4	$362K	Buy	8,393 +6,543	+354%	+$276K	﹤0.01%	1426
2015 Q3	$69K	Hold	1,850	–	–	﹤0.01%	1910
2015 Q2	$63K	Hold	1,850	–	–	﹤0.01%	2085
2015 Q1	$65K	Hold	1,850	–	–	﹤0.01%	2038
2014 Q4	$63K	Sell	1,850 -5,889	-76%	-$209K	﹤0.01%	1977
2014 Q3	$298K	Sell	7,739 -98,716	-93%	-$3.68M	﹤0.01%	1486
2014 Q2	$4.14M	Sell	106,455 -2,967	-3%	-$110K	0.02%	573
2014 Q1	$3.74M	Hold	109,422	–	–	0.02%	649
2013 Q4	$2.3M	Buy	109,422 +10,466	+11%	+$265K	0.01%	807
2013 Q3	$2.33M	Buy	98,956 +4,265	+5%	+$121K	0.01%	765
2013 Q2	$2.54M	Buy	+94,691	New	+$2.74M	0.01%	698

Other funds holding MYGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Panagora Asset Management's MYGN Position: Q2 2026 in Review

Panagora Asset Management opened a new position in Myriad Genetics (MYGN) in Q2 2026: 204,846 shares worth $1.17M. The stake represents ﹤0.01% of the portfolio and ranks #716 among its holdings. This is a return to the name: Panagora Asset Management previously reported a position in MYGN as recently as Q2 2022.

Panagora Asset Management first reported a position in MYGN in Q2 2013 and has held it in 20 quarters since. The position peaked at $4.73M in Q3 2021. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

Panagora Asset Management held 204,846 shares of Myriad Genetics worth $1.17M as of Q2 2026.
Myriad Genetics was a new Panagora Asset Management position in Q2 2026.
Myriad Genetics made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #716 holding.
Panagora Asset Management first reported a position in Myriad Genetics in Q2 2013 and has held it in 20 quarters since.
Panagora Asset Management's Myriad Genetics position peaked at $4.73M in Q3 2021.
196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.